Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05003115 · ClinicalTrials.gov registry record · NA
Motivational Strategies To Empower African Americans To Improve Dialysis Adherence
A NA study of End Stage Renal Disease on Dialysis, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 2
- Study locations
NCT05003115: Completed NA study of End Stage Renal Disease on Dialysis, sponsored by Vanderbilt University Medical Center.
NCT05003115 is a NA study of End Stage Renal Disease on Dialysis that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 30 participants, below the 74-participant average among 9 other End Stage Renal Disease on Dialysis trials with a reported enrollment target (59% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05003115, a NA study of End Stage Renal Disease on Dialysis, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study addresses the need to rigorously advance the science and understanding of the development, feasibility, acceptability and adoption of novel culturally-sensitive motivational strategies to improve dialysis treatment adherence among African Americans with end-stage kidney disease (ESKD). This study specifically aims to: 1. Gain advanced skills in the development and implementation of novel culturally sensitive motivational strategies 2. Acquire critical preliminary data for an R01-funded phase II efficacy trial testing the use of these motivational strategies to improve dialysis treatment adherence.
Primary Outcome
Abstraction of dialysis treatment adherence data from the dialysis units' records which includes data on every treatment that occurred or should have occurred within the time frame. Records will reflect dialysis treatments which were completed, shortened, missed or did not occur due to hospitalizations, ER visits or travel.
Conditions Studied
Interventions
- BEHAVIORAL Motivational interviewing
Study Locations (2)
Tennessee
- Vanderbilt Dialysis Clinic - Nashville
- Vanderbilt Dialysis Clinic East - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2022-06-06 |
| Est. Completion | 2023-01-09 |
| Phase | NA |
What the finished NCT05003115 record still lists
NCT05003115 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 74-participant average among 9 other End Stage Renal Disease on Dialysis trials with a reported enrollment target (59% lower).
The record links to 1 condition, with End Stage Renal Disease on Dialysis appearing as the primary indexed condition, and to 1 intervention - of which Motivational interviewing is the first listed.
NCT05003115 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT05003115 about?
NCT05003115 is a clinical study titled "Motivational Strategies To Empower African Americans To Improve Dialysis Adherence". This study addresses the need to rigorously advance the science and understanding of the development, feasibility, acceptability and adoption of novel culturally-sensitive motivational strategies to improve dialysis treatment adherence among African Americans with end-stage kidney disease (ESKD). Th...
What is the current status of trial NCT05003115?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2022-06-06. Estimated completion is 2023-01-09.
What conditions does trial NCT05003115 study?
This clinical trial studies the following conditions: End Stage Renal Disease on Dialysis.
What interventions are being tested in trial NCT05003115?
The interventions under investigation include: Motivational interviewing (BEHAVIORAL).
Who is sponsoring clinical trial NCT05003115?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05003115 being conducted?
This trial has 2 study locations across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for End Stage Renal Disease on Dialysis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05003115's enrollment target sits among peer trials
30 8th of 9 higher than 1 of 9 other End Stage Renal Disease on Dialysis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other End Stage Renal Disease on Dialysis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Fight Fatigue: A Progressive Muscle Relaxation and Walking Intervention to Reduce Fatigue in Adults With ESKD
RECRUITING · NA
-
Comparing Surgical and Endovascular Arteriovenous Fistula Creation
RECRUITING · NA
-
The Home Blood Pressure (BP) Trial
ACTIVE NOT RECRUITING · NA
-
MoVE Trial: Motivational Strategies to Empower African Americans to Improve Dialysis Adherence
ACTIVE NOT RECRUITING · NA
-
First Evaluation of the Moda-Flx Hemodialysis System™ in Real World Clinical Settings
COMPLETED · NA
-
The Study of Intradialytic Symptoms in Subjects Treated With Qd 500vs Qd 300
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI